Vasoconstrictively acting AT1R A1166C and NOS3 4/5 polymorphisms in recurrent spontaneous abortions (RSA)

American Journal of Reproductive Immunology

Volumn 51, Issue 5, 2004, Pages 323-328

  Buchholz, Tina ^a   Lohse, Peter ^b   Kosian, Elke ^a,b   Thaler, Christian J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Endothelial nitric oxide synthase; Habitual miscarriages; Placental perfusion; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENE PRODUCT;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FIBRINOLYSIS; GENE EXPRESSION REGULATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PLACENTA CIRCULATION; PLACENTA PERFUSION; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RECURRENT ABORTION; REGULATORY MECHANISM; SPONTANEOUS ABORTION; TISSUE PERFUSION; VASOCONSTRICTION;

EID: 2942659248     PISSN: 10467408     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2004.00163.x     Document Type: Article

References (31)

1. Blumenfeld Z, Brenner B: Thrombophilia-associated pregnancy wastage. Fertil Steril 1999; 72:765-774.
2. Kutteh WH, Park VM, Deitcher SR: Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. Fertil Steril 1999; 71:1048-1053.
3. Younis JS, Brenner B, Ohel G, Tal J, Lanir N, Ben Ami M: Activated protein C resistance and factor V Leiden mutation can be associated with first-as well as second-trimester recurrent pregnancy loss. Am J Reprod Immunol 2000; 43:31-35.
4. Pihusch R, Buchholz T, Lohse P, Rübsamen H, Rogenhofer N, Hasbargen U, Hiller E, Thaler CJ: Thrombophilic gene mutations and recurrent spontaneous abortion: Prothrombin mutation increases the risk in the first trimester. Am J Reprod Immunol 2001; 46:124-131.
5. Kim DK, Kim JW, Kim S, Gwon HC, Ryu JC, Huh JE, Choo JA, Choi Y, Rhee CH, Lee WR: Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1. Arterioscler Thromb Vasc Biol 1997; 17:3242-3247.
6. Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Grilli M, Simone P, Panico S, Mancini M: Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 1994; 14:1741-1745.
7. Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM: 4G/5G polyinorphisin of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost 1998; 80:956-960.
8. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A: Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001; 97:44-48.
9. Buchholz T, Lohse P, Rogenhofer N, Kosian E, Pihusch R, Thaler CJ: Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages. Hum Reprod 2003; 18:2473-2477.
10. Alhenc-Gelas F, Tache A, Saint-Andre JP, Milliez J, Sureau C, Corvol P, Menard J: The renin-angiotensin system in pregnancy and parturition. Adv Nephrol Necker Hosp 1986; 15:25-33.
11. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52:11-34.
12. Duncan JA, Scholey JW, Miller JA: Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes. Curr Opin Nephrol Hypertens 2001; 10:111-116.
13. Buraczynska M, Pijanowski Z, Spasiewicz D, Nowicka T, Sodolski T, Widomska-Czekajska T, Ksiazek A: Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol 2003; 58:1-9.
14. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S, Marcucci R, Brunelli T, Mello G, Parretti E, Pepe G, Abbate R: Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis 2000; 11:657-662.
15. Bouba I, Makrydimas G, Kalaitzidis R, Lolis DE, Siamopoulos KC, Georgiou I: Interaction between the polymorphisms of the renin-angiotensin system in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003; 110:811.
16. Ignarro LJ: Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990; 30:535-560.
17. Wang XL, Wang J: Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000; 70:241-251.
18. Rossmanith WG, Hoffmeister U, Wolfahrt S, Kleine B, McLean M, Jacobs RA, Grossman AB: Expression and functional analysis of endothelial nitric oxide synthase (eNOS) in human placenta. Mol Hum Reprod 1999; 5:487-494.
19. Zygmunt M, Herr F, Keller-Schönwein S, Rao CV, Lang U, Preissner KT: Human chorionic gonadotropin (hCG) is an angiogenetic factor for uterine endothelial cells in vitro. J Clin Endocrinol Metab 2002; 87:5290-5296.
20. Coto E, Rodrigo L, Alvarez R, Fuentes D, Rodriguez M, Menendez LG, Ciriza C, Gonzalez P, Alvarez V: Variation at the angiotensin-converting enzyme and endothelial nitric oxide synthase genes is associated with the risk of esophageal varices among patients with alcoholic cirrhosis. J Cardiovasc Pharmacol 2001; 38:833-839.
21. Tempfer C, Unfried G, Zeillinger R, Hefler L, Nagele F, Huber JC: Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Hum Reprod 2001; 16:1644-1647.
22. Hefler LA, Tempfer CB, Bashford MT, Unfried G, Zeillinger R, Schneeberger C, Koelbl H, Nagele F, Huber JC: Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1 beta gene promoter in women with idiopathic recurrent miscarriage. Mol Hum Reprod 2002; 8:95-100.
23. Ogasawara MS, Aoki K, Katano K, Ozaki Y, Suzumori K: Factor XII but not protein C, protein S, antithrombin III, or factor XIII is a predictor of recurrent miscarriage. Fertil Steril 2001; 75:916-919.
24. Coumans AB, Huijgens PC, Jakobs C, Schats R, de Vries JI, van Pampus MG, Dekker GA: Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion. Hum Reprod 1999; 14:211-214.
25. Alvarez R, Reguero JR, Batalla A, Iglesias-Cubero G, Cortina A, Alvarez V, Coto E: Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease. Cardiovasc Res 1998; 40:375-379.
26. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, Ochiai H, Kosuge M, Watanabe Y, Yoshii Y, Kihara M, Kimura K, Ishii M, Umemura S: Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32:521-526.
27. Wattanapitayakul SK, Mihm MJ, Young AP, Bauer JA: Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism. Trends Pharmacol Sci 2001; 22:361-368.
28. Lee KB, Kim UK: Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD. Yonsei Med 2003; 44:641-647.
29. Hefler LA, Worda C, Huber JC, Tempfer CB: A polymorphism. of the Nos3 gene and age at natural menopause. Fertil Steril 2002; 78:1184-1186.
30. Jaffe R: Development of early uteroplacental circulation. Early Pregnancy 2001; 5:34-35.
31. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 1996; 274:995-998.